Madhya Pradesh brings up the rear among top 10 States
Maharashtra recorded the highest number of deaths due to serious adverse events (SAEs) during drug trials, while Madhya Pradesh saw the least number of such deaths.
According to data disclosed by the Drug Controller-General of India, during the 49-month period (January 2008-January 2012), the country recorded 2,061 drug trial-related deaths.
But data has been given only for 1,603 of the 2,061 deaths.
Maharashtra recorded the highest number of 268 deaths to stand first among the top five States.
It is followed by Andhra Pradesh (153), Delhi/National Capital Region (97), Gujarat (87) and Karnataka (78).
Tamil Nadu, accounting for 46 deaths, Rajasthan (43), West Bengal (28), Uttar Pradesh (28) and Madhya Pradesh (26) bring up the bottom five.